Company performance
Add to research
Loading...
Description
Add to research
DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerDMTK
- PriceN/A
Trading Information
- Market cap$0.00M
- Float91.80%
- Average Daily Volume (1m)2,182
- Average Daily Volume (3m)36,746
- EPS-$2.69
Company
- Revenue$15.66M
- Rev growth (1yr)10.58%
- Net income-$20.01M
- Gross margin18.54%
- EBITDA margin-462.99%
- EBITDA-$17.80M
- EV$39.05M
- EV/Revenue2.49
- P/EN/A
- P/S0.00
- P/BN/A
- Debt/Equity134.19
Documents
Add to research
SEC Filings
Factset Street Account